 | • レポートコード：MRC2-11QY04416 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺水腫のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院・診療所、学術機関、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺水腫の競争状況、市場シェア ・世界の肺水腫市場：種類別市場規模 2015年-2020年（診断、治療） ・世界の肺水腫市場：種類別市場規模予測 2021年-2026年（診断、治療） ・世界の肺水腫市場：用途別市場規模 2015年-2020年（病院・診療所、学術機関、小売薬局） ・世界の肺水腫市場：用途別市場規模予測 2021年-2026年（病院・診療所、学術機関、小売薬局） ・北米の肺水腫市場分析：米国、カナダ ・ヨーロッパの肺水腫市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺水腫市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺水腫市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺水腫市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer Inc. (US)、ARGON MEDICAL (US)、Edwards Lifesciences Corporation (US)、BD (US)、Alcaliber S.A. (Spain)、Lupin Pharmaceuticals(India)、Vitaltec Corporation (China)、Medtronic (US)、Koninklijke Philips N.V. (The Netherlands)、Siemens Healthcare GmbH (Germany)、Hitachi Medical Corporation (US)、Canon Medical Systems Corporation (Japan) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pulmonary edema or lung congestion is a medical condition characterized by the presence of excessive fluid in the lungs. This may interfere with the exchange of gases leading to respiratory failures.
America dominates the global pulmonary edema market owing to a well-developed healthcare sector and high per capita healthcare expenditure. Moreover, the presence of developed economies like U.S. and Canada and global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the regional boundaries of the Americas fuels the market growth.
Market Analysis and Insights: Global Pulmonary Edema Market
The global Pulmonary Edema market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pulmonary Edema Scope and Market Size
Pulmonary Edema market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Edema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer Inc. (US)
ARGON MEDICAL (US)
Edwards Lifesciences Corporation (US)
BD (US)
Alcaliber S.A. (Spain)
Lupin Pharmaceuticals(India)
Vitaltec Corporation (China)
Medtronic (US)
Koninklijke Philips N.V. (The Netherlands)
Siemens Healthcare GmbH (Germany)
Hitachi Medical Corporation (US)
Canon Medical Systems Corporation (Japan)
Market segment by Type, the product can be split into
Diagnosis
Treatment
Market segment by Application, split into
Hospitals & Clinics
Academic Institutes
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pulmonary Edema Revenue
1.4 Market by Type
1.4.1 Global Pulmonary Edema Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Pulmonary Edema Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Academic Institutes
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Edema Market Perspective (2015-2026)
2.2 Global Pulmonary Edema Growth Trends by Regions
2.2.1 Pulmonary Edema Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pulmonary Edema Historic Market Share by Regions (2015-2020)
2.2.3 Pulmonary Edema Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pulmonary Edema Market Growth Strategy
2.3.6 Primary Interviews with Key Pulmonary Edema Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Edema Players by Market Size
3.1.1 Global Top Pulmonary Edema Players by Revenue (2015-2020)
3.1.2 Global Pulmonary Edema Revenue Market Share by Players (2015-2020)
3.1.3 Global Pulmonary Edema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pulmonary Edema Market Concentration Ratio
3.2.1 Global Pulmonary Edema Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pulmonary Edema Revenue in 2019
3.3 Pulmonary Edema Key Players Head office and Area Served
3.4 Key Players Pulmonary Edema Product Solution and Service
3.5 Date of Enter into Pulmonary Edema Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pulmonary Edema Historic Market Size by Type (2015-2020)
4.2 Global Pulmonary Edema Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pulmonary Edema Market Size by Application (2015-2020)
5.2 Global Pulmonary Edema Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pulmonary Edema Market Size (2015-2020)
6.2 Pulmonary Edema Key Players in North America (2019-2020)
6.3 North America Pulmonary Edema Market Size by Type (2015-2020)
6.4 North America Pulmonary Edema Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pulmonary Edema Market Size (2015-2020)
7.2 Pulmonary Edema Key Players in Europe (2019-2020)
7.3 Europe Pulmonary Edema Market Size by Type (2015-2020)
7.4 Europe Pulmonary Edema Market Size by Application (2015-2020)
8 China
8.1 China Pulmonary Edema Market Size (2015-2020)
8.2 Pulmonary Edema Key Players in China (2019-2020)
8.3 China Pulmonary Edema Market Size by Type (2015-2020)
8.4 China Pulmonary Edema Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pulmonary Edema Market Size (2015-2020)
9.2 Pulmonary Edema Key Players in Japan (2019-2020)
9.3 Japan Pulmonary Edema Market Size by Type (2015-2020)
9.4 Japan Pulmonary Edema Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pulmonary Edema Market Size (2015-2020)
10.2 Pulmonary Edema Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pulmonary Edema Market Size by Type (2015-2020)
10.4 Southeast Asia Pulmonary Edema Market Size by Application (2015-2020)
11 India
11.1 India Pulmonary Edema Market Size (2015-2020)
11.2 Pulmonary Edema Key Players in India (2019-2020)
11.3 India Pulmonary Edema Market Size by Type (2015-2020)
11.4 India Pulmonary Edema Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pulmonary Edema Market Size (2015-2020)
12.2 Pulmonary Edema Key Players in Central & South America (2019-2020)
12.3 Central & South America Pulmonary Edema Market Size by Type (2015-2020)
12.4 Central & South America Pulmonary Edema Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer Inc. (US)
13.1.1 Pfizer Inc. (US) Company Details
13.1.2 Pfizer Inc. (US) Business Overview
13.1.3 Pfizer Inc. (US) Pulmonary Edema Introduction
13.1.4 Pfizer Inc. (US) Revenue in Pulmonary Edema Business (2015-2020))
13.1.5 Pfizer Inc. (US) Recent Development
13.2 ARGON MEDICAL (US)
13.2.1 ARGON MEDICAL (US) Company Details
13.2.2 ARGON MEDICAL (US) Business Overview
13.2.3 ARGON MEDICAL (US) Pulmonary Edema Introduction
13.2.4 ARGON MEDICAL (US) Revenue in Pulmonary Edema Business (2015-2020)
13.2.5 ARGON MEDICAL (US) Recent Development
13.3 Edwards Lifesciences Corporation (US)
13.3.1 Edwards Lifesciences Corporation (US) Company Details
13.3.2 Edwards Lifesciences Corporation (US) Business Overview
13.3.3 Edwards Lifesciences Corporation (US) Pulmonary Edema Introduction
13.3.4 Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Business (2015-2020)
13.3.5 Edwards Lifesciences Corporation (US) Recent Development
13.4 BD (US)
13.4.1 BD (US) Company Details
13.4.2 BD (US) Business Overview
13.4.3 BD (US) Pulmonary Edema Introduction
13.4.4 BD (US) Revenue in Pulmonary Edema Business (2015-2020)
13.4.5 BD (US) Recent Development
13.5 Alcaliber S.A. (Spain)
13.5.1 Alcaliber S.A. (Spain) Company Details
13.5.2 Alcaliber S.A. (Spain) Business Overview
13.5.3 Alcaliber S.A. (Spain) Pulmonary Edema Introduction
13.5.4 Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Business (2015-2020)
13.5.5 Alcaliber S.A. (Spain) Recent Development
13.6 Lupin Pharmaceuticals(India)
13.6.1 Lupin Pharmaceuticals(India) Company Details
13.6.2 Lupin Pharmaceuticals(India) Business Overview
13.6.3 Lupin Pharmaceuticals(India) Pulmonary Edema Introduction
13.6.4 Lupin Pharmaceuticals(India) Revenue in Pulmonary Edema Business (2015-2020)
13.6.5 Lupin Pharmaceuticals(India) Recent Development
13.7 Vitaltec Corporation (China)
13.7.1 Vitaltec Corporation (China) Company Details
13.7.2 Vitaltec Corporation (China) Business Overview
13.7.3 Vitaltec Corporation (China) Pulmonary Edema Introduction
13.7.4 Vitaltec Corporation (China) Revenue in Pulmonary Edema Business (2015-2020)
13.7.5 Vitaltec Corporation (China) Recent Development
13.8 Medtronic (US)
13.8.1 Medtronic (US) Company Details
13.8.2 Medtronic (US) Business Overview
13.8.3 Medtronic (US) Pulmonary Edema Introduction
13.8.4 Medtronic (US) Revenue in Pulmonary Edema Business (2015-2020)
13.8.5 Medtronic (US) Recent Development
13.9 Koninklijke Philips N.V. (The Netherlands)
13.9.1 Koninklijke Philips N.V. (The Netherlands) Company Details
13.9.2 Koninklijke Philips N.V. (The Netherlands) Business Overview
13.9.3 Koninklijke Philips N.V. (The Netherlands) Pulmonary Edema Introduction
13.9.4 Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Business (2015-2020)
13.9.5 Koninklijke Philips N.V. (The Netherlands) Recent Development
13.10 Siemens Healthcare GmbH (Germany)
13.10.1 Siemens Healthcare GmbH (Germany) Company Details
13.10.2 Siemens Healthcare GmbH (Germany) Business Overview
13.10.3 Siemens Healthcare GmbH (Germany) Pulmonary Edema Introduction
13.10.4 Siemens Healthcare GmbH (Germany) Revenue in Pulmonary Edema Business (2015-2020)
13.10.5 Siemens Healthcare GmbH (Germany) Recent Development
13.11 Hitachi Medical Corporation (US)
10.11.1 Hitachi Medical Corporation (US) Company Details
10.11.2 Hitachi Medical Corporation (US) Business Overview
10.11.3 Hitachi Medical Corporation (US) Pulmonary Edema Introduction
10.11.4 Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Business (2015-2020)
10.11.5 Hitachi Medical Corporation (US) Recent Development
13.12 Canon Medical Systems Corporation (Japan)
10.12.1 Canon Medical Systems Corporation (Japan) Company Details
10.12.2 Canon Medical Systems Corporation (Japan) Business Overview
10.12.3 Canon Medical Systems Corporation (Japan) Pulmonary Edema Introduction
10.12.4 Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Business (2015-2020)
10.12.5 Canon Medical Systems Corporation (Japan) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pulmonary Edema Key Market Segments
Table 2. Key Players Covered: Ranking by Pulmonary Edema Revenue
Table 3. Ranking of Global Top Pulmonary Edema Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pulmonary Edema Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis
Table 6. Key Players of Treatment
Table 7. Global Pulmonary Edema Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pulmonary Edema Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pulmonary Edema Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pulmonary Edema Market Share by Regions (2015-2020)
Table 11. Global Pulmonary Edema Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pulmonary Edema Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pulmonary Edema Market Growth Strategy
Table 17. Main Points Interviewed from Key Pulmonary Edema Players
Table 18. Global Pulmonary Edema Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pulmonary Edema Market Share by Players (2015-2020)
Table 20. Global Top Pulmonary Edema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Edema as of 2019)
Table 21. Global Pulmonary Edema by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pulmonary Edema Product Solution and Service
Table 24. Date of Enter into Pulmonary Edema Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pulmonary Edema Market Size Share by Type (2015-2020)
Table 28. Global Pulmonary Edema Revenue Market Share by Type (2021-2026)
Table 29. Global Pulmonary Edema Market Size Share by Application (2015-2020)
Table 30. Global Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pulmonary Edema Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pulmonary Edema Market Share (2019-2020)
Table 34. North America Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pulmonary Edema Market Share by Type (2015-2020)
Table 36. North America Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pulmonary Edema Market Share by Application (2015-2020)
Table 38. Europe Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pulmonary Edema Market Share (2019-2020)
Table 40. Europe Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pulmonary Edema Market Share by Type (2015-2020)
Table 42. Europe Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pulmonary Edema Market Share by Application (2015-2020)
Table 44. China Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pulmonary Edema Market Share (2019-2020)
Table 46. China Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 47. China Pulmonary Edema Market Share by Type (2015-2020)
Table 48. China Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 49. China Pulmonary Edema Market Share by Application (2015-2020)
Table 50. Japan Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pulmonary Edema Market Share (2019-2020)
Table 52. Japan Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pulmonary Edema Market Share by Type (2015-2020)
Table 54. Japan Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pulmonary Edema Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pulmonary Edema Market Share (2019-2020)
Table 58. Southeast Asia Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pulmonary Edema Market Share by Type (2015-2020)
Table 60. Southeast Asia Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pulmonary Edema Market Share by Application (2015-2020)
Table 62. India Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pulmonary Edema Market Share (2019-2020)
Table 64. India Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 65. India Pulmonary Edema Market Share by Type (2015-2020)
Table 66. India Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 67. India Pulmonary Edema Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pulmonary Edema Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pulmonary Edema Market Share (2019-2020)
Table 70. Central & South America Pulmonary Edema Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pulmonary Edema Market Share by Type (2015-2020)
Table 72. Central & South America Pulmonary Edema Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pulmonary Edema Market Share by Application (2015-2020)
Table 74. Pfizer Inc. (US) Company Details
Table 75. Pfizer Inc. (US) Business Overview
Table 76. Pfizer Inc. (US) Product
Table 77. Pfizer Inc. (US) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 78. Pfizer Inc. (US) Recent Development
Table 79. ARGON MEDICAL (US) Company Details
Table 80. ARGON MEDICAL (US) Business Overview
Table 81. ARGON MEDICAL (US) Product
Table 82. ARGON MEDICAL (US) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 83. ARGON MEDICAL (US) Recent Development
Table 84. Edwards Lifesciences Corporation (US) Company Details
Table 85. Edwards Lifesciences Corporation (US) Business Overview
Table 86. Edwards Lifesciences Corporation (US) Product
Table 87. Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 88. Edwards Lifesciences Corporation (US) Recent Development
Table 89. BD (US) Company Details
Table 90. BD (US) Business Overview
Table 91. BD (US) Product
Table 92. BD (US) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 93. BD (US) Recent Development
Table 94. Alcaliber S.A. (Spain) Company Details
Table 95. Alcaliber S.A. (Spain) Business Overview
Table 96. Alcaliber S.A. (Spain) Product
Table 97. Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 98. Alcaliber S.A. (Spain) Recent Development
Table 99. Lupin Pharmaceuticals(India) Company Details
Table 100. Lupin Pharmaceuticals(India) Business Overview
Table 101. Lupin Pharmaceuticals(India) Product
Table 102. Lupin Pharmaceuticals(India) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 103. Lupin Pharmaceuticals(India) Recent Development
Table 104. Vitaltec Corporation (China) Company Details
Table 105. Vitaltec Corporation (China) Business Overview
Table 106. Vitaltec Corporation (China) Product
Table 107. Vitaltec Corporation (China) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 108. Vitaltec Corporation (China) Recent Development
Table 109. Medtronic (US) Business Overview
Table 110. Medtronic (US) Product
Table 111. Medtronic (US) Company Details
Table 112. Medtronic (US) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 113. Medtronic (US) Recent Development
Table 114. Koninklijke Philips N.V. (The Netherlands) Company Details
Table 115. Koninklijke Philips N.V. (The Netherlands) Business Overview
Table 116. Koninklijke Philips N.V. (The Netherlands) Product
Table 117. Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 118. Koninklijke Philips N.V. (The Netherlands) Recent Development
Table 119. Siemens Healthcare GmbH (Germany) Company Details
Table 120. Siemens Healthcare GmbH (Germany) Business Overview
Table 121. Siemens Healthcare GmbH (Germany) Product
Table 122. Siemens Healthcare GmbH (Germany) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 123. Siemens Healthcare GmbH (Germany) Recent Development
Table 124. Hitachi Medical Corporation (US) Company Details
Table 125. Hitachi Medical Corporation (US) Business Overview
Table 126. Hitachi Medical Corporation (US) Product
Table 127. Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 128. Hitachi Medical Corporation (US) Recent Development
Table 129. Canon Medical Systems Corporation (Japan) Company Details
Table 130. Canon Medical Systems Corporation (Japan) Business Overview
Table 131. Canon Medical Systems Corporation (Japan) Product
Table 132. Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Business (2015-2020) (Million US$)
Table 133. Canon Medical Systems Corporation (Japan) Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Edema Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Pulmonary Edema Market Share by Application: 2020 VS 2026
Figure 5. Hospitals & Clinics Case Studies
Figure 6. Academic Institutes Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Pulmonary Edema Report Years Considered
Figure 9. Global Pulmonary Edema Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pulmonary Edema Market Share by Regions: 2020 VS 2026
Figure 11. Global Pulmonary Edema Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pulmonary Edema Market Share by Players in 2019
Figure 14. Global Top Pulmonary Edema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Edema as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pulmonary Edema Revenue in 2019
Figure 16. North America Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pulmonary Edema Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
糖尿病性黄斑浮腫治療の世界市場（～2026年） Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Increasing prevalence of diabetes in the prime factor driving …- 特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…
- 肺動脈性肺高血圧症（PAH）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Arterial Hypertension (PAH) S…
- 肺ドラッグデリバリーシステム（PDDS）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Drug Delivery System (PDDS) Market The global Pulmonary Drug Delivery System (PDDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Drug Delivery System (PDDS) S…
- 慢性閉塞性肺疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Treatment Market The global Chronic Obstructive Pulmonary Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Obstructive…